Chr. Hansen to acquire DIAL culture production and strain collection

Chr. Hansen to acquire DIAL culture production and strain collection
Press Release | Oct 09. 2015 06:34 GMT



Joint press release from Dairy Innovation Australia Ltd (DIAL) and Chr. Hansen A/S:

The Board of Dairy Innovation Australia Ltd (DIAL) is pleased to announce that they have entered into a contract to finalize the sale of the DIAL culture production unit and strain collection to Chr. Hansen Holding A/S (Denmark) and Chr. Hansen Pty Ltd (Australia), a wholly owned subsidiary. The sale of this business unit is in line with the strategic review conducted by the DIAL Board. It is anticipated that this transaction will be completed in November 2015.

Peter Boyden, Chairman of DIAL, says: “Securing a key international purchaser in Chr. Hansen validates our decision to separate the Cultures Production Unit from the remaining consultancy functions of DIAL. It is important to the DIAL Board to know the supply of cultures to the Australian industry will be serviced by a global leader in the sector.”

The Danish-based biotechnology company Chr. Hansen is a global, leading expert in fermentation technology, with culture production facilities in Denmark, France the USA and, with this acquisition, Australia. The company is listed on the Nasdaq Copenhagen stock exchange.

Chr. Hansen Pty Ltd has been in Australia since 1951 and has a long history as a partner servicing the Australian dairy industry. Today, Chr. Hansen Pty Ltd is based in Melbourne with sales, laboratory applications, marketing and supply chains servicing the dairy, general food, beverage and pharmaceutical industries in all of Australia and New Zealand.

Kylie Evans, Country Manager at Chr. Hansen Pty Ltd says: “We are committed to best-in-class coverage and service to customers and we are proud to be trusted by the major Australian cheesemakers to supply the key ingredients to their important brands. Now we look forward to nurturing the starter culture business within the Chr. Hansen family and becoming a stronger partner to our customers”

A number of key Dairy Innovation Australia staff will join Chr. Hansen and it is intended to continue production for key clients at the existing DIAL facility for 12 months whilst a long term future location is evaluated.

For further information, please contact:

Lesley MacLeod, CEO DIAL Tel: +61 3 9974 8711 / +61 4 2092 1737

Kylie Evans, Country Manager, Chr. Hansen Pty Ltd. Tel: +61 3 9721 1035 / +61 4 55425459


科汉森是为食品、营养、制药和农业行业开发天然解决方案的一家全球领先的生物科学公司。我们为各种食品、糖果、饮料、膳食补充剂、动物饲料和植物保护开发和生产发酵剂、酶、益生菌和天然色素。我们的产品创新基于大约 40,000 株微生物菌株——我们喜欢称之为“有益菌群”。我们的解决方案帮助食品制造商实现以更少的资源生产更多的产品,同时也减少了化学添加剂和其他合成物添加剂的使用,这使得我们的产品与当今世界息息相关。可持续性是科汉森改善食物和健康的愿景不可分割的一部分。2019 年,科汉森被 Corporate Knights 评为全球最可持续发展的公司,这要归功于我们为可持续发展付出的巨大努力以及我们与客户建立的众多合作伙伴关系。145 年来,我们一直在不断地为我们的合作伙伴以及全球终端消费者创造价值。令我们感到自豪的是,每天有超过 10 亿人在消费含有我们天然成分的产品。科汉森成立于 1874 年,并已在哥本哈根证券交易所上市。

NewsAttachments

共享